HPV cfDNA is a highly effective tumor marker for monitoring disease progression and treatment response in HPV-positive ...

Almirall’s scientific presence at the 34th EADV congress reflects its broad portfolio of dermatological treatments and ...

All 172 patients have now entered the 12-month follow-up phaseTrial involves larger surface areas, building on the approval in October 2024 for use of up to 3 tubes of Ameluz® per treatmentStudy ...

A simple AI model has been shown to perform on a par with experienced dermatologists when assessing the aggressiveness of a ...